Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Conserved regions in HIV-1 refer to stretches of the viral genome or protein sequences that remain relatively unchanged across different viral strains and subtypes. These regions are critical for essential viral functions, such as entry, replication, and assembly, making them attractive targets for therapeutic interventions and vaccine design. Key conserved regions include the CD4 binding site (CD4bs) and V3 loop on gp120, N-heptad repeat (NHR), fusion peptide proximal region (FPPR), membrane-proximal external region (MPER), and fusion peptide (FP) on gp41, and core domains of reverse transcriptase (RT). These regions are targeted by antiretroviral drugs and are the focus of vaccine development efforts to elicit broadly neutralizing antibodies and T cell responses.
Targeting conserved regions to disrupt viral entry, replication, or assembly, or to elicit broadly neutralizing antibody responses.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus Type 1 (HIV-1) Conserved Regions (HIV-1 Conserved Regions).